BioAge Labs (BIOA) Enterprise Value (2024 - 2026)

BioAge Labs has disclosed Enterprise Value across 3 years of filings, most recently posting $495.9 million for Q2 2026.

• In Q2 2026, Enterprise Value rose 304.66% year-over-year to $495.9 million; the TTM figure through Jun 2026 stood at $495.9 million (up 304.66% YoY), while the FY2025 annual figure was $213.5 million, up 173.07% from the prior year.
• Enterprise Value came in at $495.9 million for Q2 2026 at BioAge Labs, up from $250.0 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $495.9 million in Q2 2026 to a low of -$292.2 million in Q4 2024.
• Average Enterprise Value over 3 years is -$31.9 million, with a median of -$198.8 million recorded in 2025.
• Year-over-year, Enterprise Value surged 40.68% in 2025 and soared 304.66% in 2026.
• Over 3 years, Enterprise Value stood at -$292.2 million in 2024, then soared by 173.07% to $213.5 million in 2025, then surged by 132.24% to $495.9 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $495.9 million in Q2 2026, $250.0 million in Q1 2026, and $213.5 million in Q4 2025.